Showing 821-830 of 964 results for "".
- ASDS Abstract Highlights Potential of ALA-PDThttps://modernaesthetics.com/news/asds-abstract-highlights-potential-of-ala-pdt/2473704/Photodynamic therapy (PDT) with aminolevulonic acid (ALA) was the topic of the top 10 abstract “Fine Wrinkles and the Art of Light,” presented by Luke Horton, MD, at the 2024 American Society for Dermatologic Surgery (ASDS) Annual Meeting. Dr. Horton performed a study along
- Dr. Jason Bloom Shares Latest Innovations from Korean Skincare on Philadelphia Newscasthttps://modernaesthetics.com/news/dr-jason-bloom-shares-latest-skincare-innovations-from-korean-skincare/2473702/Korean skincare, also known as K-Beauty, has become increasingly popular in the United States as Americans look to achieve “glass” skin. Social media, particularly TikTok, has played a large role in promoting K-Beauty lines and products. Jason Bloom, MD, is the founder
- New Data Demonstrates Long-Term Safety, Efficacy of Galderma’s RelabotulinumtoxinAhttps://modernaesthetics.com/news/new-data-demonstrates-long-term-safety-efficacy-of-galdermas-relabotulinumtoxina/2473698/Galderma presented new phase III data from the READY-4 clinical trial at the American Society for Dermatologic Surgery (ASDS) 2024 Annual Meeting last week. The data demonstrates the long-term safety of RelabotulinumtoxinA (RelfydessTM) for frown lines and crow’s feet after repea
- Allergan Aesthetics to Present New Data at 2024 ASDS Conferencehttps://modernaesthetics.com/news/allergan-aesthetics-to-present-new-data-at-2024-asds-conference/2473693/Allergan Aesthetics will be presenting new data at the 2024 American Society for Dermatologic Surgery (ASDS) conference, which is underway through October 20. The data will showcase efficacy, safety and patient-reported outcomes across its facial injectable portfolio. Four of the 12 abs
- DefenAge 360-Rejuvenation Nail Root Serum Earns Allure Awardhttps://modernaesthetics.com/news/defenage-360-rejuvenation-nail-root-serum-earns-allure-award/2473680/DefenAge® Skincare’s 360-Rejuvenation Nail Root Serum earned a 2024 Allure Best of Beauty Award, DefenAge announced. “This recognition marks a significant milestone for the brand,” the company said in a press release, “solidifying its commitment to delivering
- Report: Nonsurgical Aesthetics Revenues Up 9% From Last Yearhttps://modernaesthetics.com/news/report-nonsurgical-aesthetics-revenues-up-9-from-last-year/2473677/Data and analytics solutions provider Guidepoint Qsight and investment banking and management consulting firm Skytale Group released a new report on the state of the aesthetics industry, highlighting the continued expansion of the US market. Combined nonsurgical revenues increased by 9%
- Ozempic Potentially Linked to Facial Edema After Fillerhttps://modernaesthetics.com/news/ozempic-potentially-linked-to-facial-edema-after-filler/2473672/The authors of a recent Journal of Craniofacial Surgery article speculate that some medications may be capable of initiating immune responses, such as facial edema. Dr. Nathaly de Oliveira Ciaramicolo and co-authors discussed a case of a patient who presented with significant facial ede
- Skinbetter Science Launches Refining Foam Cleanserhttps://modernaesthetics.com/news/skinbetter-science-launches-refining-foam-cleanser/2473662/A new product from Skinbetter Science launched this week. The Refining Foam Cleanser is said to be a multi-tasking, velvety-soft cleansing foam that exfoliates and renews the skin. With a goal of leaving the skin feeling soft and smooth with a bright, more refined look, the cleanser is
- Novaestiq’s Partner Croma-Pharma Submits Final Application for Hyaluronic Acid Dermal Fillerhttps://modernaesthetics.com/news/novaestiqs-partner-croma-pharma-submits-final-application-for-hyaluronic-acid-dermal-filler/2473657/Novaestiq Corp., an aesthetic company that focuses on delivering intelligent and innovative skin solutions to practices and patients, announced its partner Croma-Pharma GmbH finalized the submission of its premarket approval to the US Food and Drug Administration (FDA) for the saypha MagIQ hyalur
- Powered By MRP Gets Series A Investmenthttps://modernaesthetics.com/news/power-by-mrp-gets-series-a-investment/2473629/“Strong tailwinds behind the aesthetics market” was part of the impetus for two prominent growth equity firms to form a strategic partnership with aesthetics device company Powered By MRP, according to a press release. The Series A investment by Aries Capital Partners and Sw